The relevance of xenobiotic metabolism in the interindividual susceptibility to chemicals.
Biotransformation enzymes may catalyze either detoxication or bioactivation reactions; indeed, many xenobiotics exert their toxic effects after metabolic activation to electrophilic chemicals, interacting with nucleophilic sites on cellular macromolecules. On the other hand, by increasing xenobiotic hydrophilicity, the drug-metabolizing enzymes favors excretion of lipophilic chemicals, not allowing their bioaccumulation up to toxic levels. The expression of the enzymes of the drug-metabolizing system is modulated by genetic, pathological, developmental, environmental and dietary factors. Genetic polymorphism resulting in interindividual and interethnic variation in xenobiotic metabolism is responsible for differences in the susceptibility to chemical-induced toxicity and carcinogenicity, allowing the identification of people at increased risk. Moreover, differences in drug metabolism may correspond to variability in drug response during pharmacological therapy, which can be manifest either as adverse reactions or as a lack of benefit.
Testai
E
E
Comparative Toxicology and Ecotoxicology Department, Istituto Superiore di Sanita, Rome, Italy. testai@iss.it
D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism; D004785:Environmental Pollutants / Q000493:pharmacokinetics*; D020022:Genetic Predisposition to Disease; D006801:Humans; D011110:Polymorphism, Genetic
D004785:Environmental Pollutants; D019389:Cytochrome P-450 CYP2D6